National Research (NASDAQ:NRC) Now Covered by Citizens Jmp

Research analysts at Citizens Jmp assumed coverage on shares of National Research (NASDAQ:NRC) in a note issued to investors on Monday, Marketbeat reports. The firm set a “mkt outperform” rating and a $23.00 price target on the stock. Citizens Jmp’s target price points to a potential upside of 22.07% from the stock’s previous close.

Separately, Weiss Ratings raised shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 29th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, National Research currently has an average rating of “Hold” and a consensus target price of $23.00.

National Research Stock Performance

Shares of NRC stock traded up $0.30 during mid-day trading on Monday, reaching $18.84. The stock had a trading volume of 4,566 shares, compared to its average volume of 112,653. The firm’s 50 day simple moving average is $18.44 and its 200 day simple moving average is $17.66. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48. National Research has a one year low of $11.01 and a one year high of $22.79. The firm has a market cap of $428.63 million, a PE ratio of 48.03 and a beta of 0.36.

National Research (NASDAQ:NRC) last released its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The business had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

Hedge Funds Weigh In On National Research

A number of hedge funds have recently modified their holdings of the stock. Cubist Systematic Strategies LLC acquired a new stake in National Research in the 1st quarter valued at $118,000. AQR Capital Management LLC raised its stake in National Research by 168.6% during the first quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock worth $1,384,000 after acquiring an additional 67,882 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of National Research by 394.2% during the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after acquiring an additional 41,806 shares during the period. Strs Ohio bought a new position in shares of National Research during the first quarter valued at $33,000. Finally, M&T Bank Corp boosted its stake in shares of National Research by 6.4% in the 2nd quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock valued at $229,000 after purchasing an additional 823 shares in the last quarter. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.